Cleared Traditional

K955031 - MAXISTIM (FDA 510(k) Clearance)

Class II Anesthesiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K955031 · Life-Tech Intl., Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1996
Decision
404d
Days
Class 2
Risk

K955031 is an FDA 510(k) clearance for the MAXISTIM. Classified as Stimulator, Nerve, Peripheral, Electric (product code KOI), Class II - Special Controls.

Submitted by Life-Tech Intl., Inc. (Houston, US). The FDA issued a Cleared decision on December 10, 1996 after a review of 404 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.2775 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Anesthesiology submissions.

View all Life-Tech Intl., Inc. devices

Submission Details

510(k) Number K955031 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 02, 1995
Decision Date December 10, 1996
Days to Decision 404 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
265d slower than avg
Panel avg: 139d · This submission: 404d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code KOI Stimulator, Nerve, Peripheral, Electric
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.2775
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - KOI Stimulator, Nerve, Peripheral, Electric

All 27
Devices cleared under the same product code (KOI) and FDA review panel - the closest regulatory comparables to K955031.
Neuromuscular Transmission Monitor TOF3D (2510091)
K250887 · MIPM Mammendorfer Institut f?r Physik und Medizin GmbH · Oct 2025
WiTOF
K243339 · Idmed · Jun 2025
iTOF®
K242525 · Nerbio Medical Software Platforms, Inc. · Dec 2024
Tetragraph Neuromuscular Transmission Monitor
K220530 · Senzime AB · Aug 2022
Life Scope PT BSM-1700 Series Bedside Monitor
K220976 · Nihon Kohden Corporation · Jul 2022
Neuromuscular Transmission Monitor TOF3D
K212434 · MIPM Mammendorfer Institut f?r Physik und Medizin GmbH · May 2022